Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood-Reference-Cited by-同舟云学术

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood

Published:2019-09-18 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Aris Mariana,Bravo Alicia Inés,Garcia Alvarez Heli Magalí,Carri Ibel,Podaza Enrique,Blanco Paula Alejandra,Rotondaro Cecilia,Bentivegna Sofia,Nielsen Morten,Barrio María Marcela,Mordoh José

Funder

Instituto Nacional del Cáncer

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference39 articles.

1. Mutations of the BRAF gene in human cancer;Davies;Nature.,2002

2. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med.,2011

3. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet.,2012

4. Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study;Long;Ann Oncol.,2017

5. Combined vemurafenib and cobimetinib in BRAF -mutated melanoma;Larkin;N Engl J Med.,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical applications of immunosequencing;Current Research in Translational Medicine;2024-09

2. Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study;Frontiers in Immunology;2024-04-25

3. HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy;Frontiers in Immunology;2023-08-25

4. An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases;Frontiers in Immunology;2022-04-01

5. Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF;Frontiers in Immunology;2020-06-05